Grant: CIHR Clinician Scientist - Phase 1
Université de Montréal
$172,500.00
Transcriptional regulation by SMAD3 in T-lymphocytes
FY 2008-09
Summary
T-lymphocytes are immune cells that are essential to protect us against microbes. The activation of T-lymphocytes in the face of an infection is beneficial but the spontaneous and uncontrolled activation of T-lymphocytes in healthy individuals can lead to serious illnesses. It is known that T-lymphocytes do attack the normal tissues of the body when they are not under the control of a cytokine (hormone of the immune system) called TGF-beta. TGF-beta keeps T-lymphocytes in a resting state called immune tolerance. Our study aims at unveiling how TGF-beta maintains immune tolerance in the T-lymphocytes. We plan to characterize the biological messages TGF-beta conveys to T-lymphocytes in order to prevent their activation. A deeper understanding of immune tolerance will ultimately improve the care of patients suffering from auto-immune diseases and cancer as well as transplantation recipients.
Department
Program
CIHR Clinician Scientist - Phase 1
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
174065
Name
Delisle Jean-Sébastien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Transcriptional regulation by SMAD3 in T-lymphocytes
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$172,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Chromatin; Expression Microarray; Functionnal Genomics; Immune Tolerance; Immunoprecipitation; Smad3; T-Lymphocytes; Tgf-Beta
Abstract
T-lymphocytes are immune cells that are essential to protect us against microbes. The activation of T-lymphocytes in the face of an infection is beneficial but the spontaneous and uncontrolled activation of T-lymphocytes in healthy individuals can lead to serious illnesses. It is known that T-lymphocytes do attack the normal tissues of the body when they are not under the control of a cytokine (hormone of the immune system) called TGF-beta. TGF-beta keeps T-lymphocytes in a resting state called immune tolerance. Our study aims at unveiling how TGF-beta maintains immune tolerance in the T-lymphocytes. We plan to characterize the biological messages TGF-beta conveys to T-lymphocytes in order to prevent their activation. A deeper understanding of immune tolerance will ultimately improve the care of patients suffering from auto-immune diseases and cancer as well as transplantation recipients.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Delisle, Jean-Sébastien
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $172,500~ $0~